4
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A snapshot of the Covid-19 pandemic among pregnant women in France

      research-article
      a , * , 1 , a , 1 , b , 1 , c , 1 , d , 1 , a , 1 , c , 1 , a , 1 , a , 1 , e , 1 , a , 1 , f , 1 , g , 1 , h , 1 , i , 1 , a , 1 , a , 1 , j , 1 , k , 1 , h , 1 , l , 1 , a , 1 , m , 1 , n , 1 , a , 1 , o , 1 , a , 1 , 2 , p , 1 , a , 1 , q , 1 , r , 1 , a , 1 , s , 1
      Journal of Gynecology Obstetrics and Human Reproduction
      Elsevier Masson SAS.
      COVID 19, respiratory complications, risk factors, lockdown

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          To describe the course over time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in French women from the beginning of the pandemic until mid-April, the risk profile of women with respiratory complications, and short-term pregnancy outcomes.

          Methods

          We collected a case series of pregnant women with COVID-19 in a research network of 33 French maternity units between March 1 and April 14, 2020. All cases of SARS-CoV-2 infection confirmed by a positive result on real-time reverse transcriptase polymerase chain reaction tests of a nasal sample and/or diagnosed by a computed tomography chest scan were included and analyzed. The primary outcome measures were COVID-19 requiring oxygen (oxygen therapy or noninvasive ventilation) and critical COVID-19 (requiring invasive mechanical ventilation or extracorporeal membrane oxygenation, ECMO). Demographic data, baseline comorbidities, and pregnancy outcomes were also collected.

          Results

          Active cases of COVID-19 increased exponentially during March 1-31, 2020; the numbers fell during April 1-14, after lockdown was imposed on March 17. The shape of the curve of active critical COVID-19 mirrored that of all active cases. By April 14, among the 617 pregnant women with COVID-19, 93 women (15.1%; 95%CI 12.3-18.1) had required oxygen therapy and 35 others (5.7%; 95%CI 4.0-7.8) had had a critical form of COVID-19. The severity of the disease was associated with age older than 35 years and obesity, as well as preexisting diabetes, previous preeclampsia, and gestational hypertension or preeclampsia. One woman with critical COVID-19 died (0.2%; 95%CI 0-0.9). Among the women who gave birth, rates of preterm birth in women with non-severe, oxygen-requiring, and critical COVID-19 were 13/123 (10.6%), 14/29 (48.3%), and 23/29 (79.3%) before 37 weeks and 3/123 (2.4%), 4/29 (13.8%), and 14/29 (48.3%) before 32 weeks, respectively. One neonate in the critical group died from prematurity.

          Conclusion

          COVID-19 can be responsible for significant rates of severe acute, potentially deadly, respiratory distress syndromes. The most vulnerable pregnant women, those with comorbidities, may benefit particularly from prevention measures such as a lockdown.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical Characteristics of Coronavirus Disease 2019 in China

          Abstract Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of the affected patients. Methods We extracted data regarding 1099 patients with laboratory-confirmed Covid-19 from 552 hospitals in 30 provinces, autonomous regions, and municipalities in mainland China through January 29, 2020. The primary composite end point was admission to an intensive care unit (ICU), the use of mechanical ventilation, or death. Results The median age of the patients was 47 years; 41.9% of the patients were female. The primary composite end point occurred in 67 patients (6.1%), including 5.0% who were admitted to the ICU, 2.3% who underwent invasive mechanical ventilation, and 1.4% who died. Only 1.9% of the patients had a history of direct contact with wildlife. Among nonresidents of Wuhan, 72.3% had contact with residents of Wuhan, including 31.3% who had visited the city. The most common symptoms were fever (43.8% on admission and 88.7% during hospitalization) and cough (67.8%). Diarrhea was uncommon (3.8%). The median incubation period was 4 days (interquartile range, 2 to 7). On admission, ground-glass opacity was the most common radiologic finding on chest computed tomography (CT) (56.4%). No radiographic or CT abnormality was found in 157 of 877 patients (17.9%) with nonsevere disease and in 5 of 173 patients (2.9%) with severe disease. Lymphocytopenia was present in 83.2% of the patients on admission. Conclusions During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness. Patients often presented without fever, and many did not have abnormal radiologic findings. (Funded by the National Health Commission of China and others.)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

            There is limited information describing the presenting characteristics and outcomes of US patients requiring hospitalization for coronavirus disease 2019 (COVID-19).
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis

              Background The coronavirus disease 2019 (Covid-19) outbreak is evolving rapidly worldwide. Objective To evaluate the risk of serious adverse outcomes in patients with coronavirus disease 2019 (Covid-19) by stratifying the comorbidity status. Methods We analysed the data from 1590 laboratory-confirmed hospitalised patients 575 hospitals in 31 province/autonomous regions/provincial municipalities across mainland China between December 11th, 2019 and January 31st, 2020. We analyse the composite endpoints, which consisted of admission to intensive care unit, or invasive ventilation, or death. The risk of reaching to the composite endpoints was compared according to the presence and number of comorbidities. Results The mean age was 48.9 years. 686 patients (42.7%) were females. Severe cases accounted for 16.0% of the study population. 131 (8.2%) patients reached to the composite endpoints. 399 (25.1%) reported having at least one comorbidity. The most prevalent comorbidity was hypertension (16.9%), followed by diabetes (8.2%). 130 (8.2%) patients reported having two or more comorbidities. After adjusting for age and smoking status, COPD [hazards ratio (HR) 2.681, 95% confidence interval (95%CI) 1.424–5.048], diabetes (HR 1.59, 95%CI 1.03–2.45), hypertension (HR 1.58, 95%CI 1.07–2.32) and malignancy (HR 3.50, 95%CI 1.60–7.64) were risk factors of reaching to the composite endpoints. The HR was 1.79 (95%CI 1.16–2.77) among patients with at least one comorbidity and 2.59 (95%CI 1.61–4.17) among patients with two or more comorbidities. Conclusion Among laboratory-confirmed cases of Covid-19, patients with any comorbidity yielded poorer clinical outcomes than those without. A greater number of comorbidities also correlated with poorer clinical outcomes.
                Bookmark

                Author and article information

                Contributors
                Journal
                J Gynecol Obstet Hum Reprod
                J Gynecol Obstet Hum Reprod
                Journal of Gynecology Obstetrics and Human Reproduction
                Elsevier Masson SAS.
                2468-7847
                4 June 2020
                4 June 2020
                : 101826
                Affiliations
                [a ]Assistance Publique-Hôpitaux de Paris, 75004, Paris, France
                [b ]Groupe Hospitalier Saint-Joseph, 75014, Paris, France
                [c ]Assistance Publique-Hôpitaux de Marseille, 13000, Marseille, France
                [d ]Centre Hospitalier de Pau, 64000, Pau, France
                [e ]Centre Hospitalo-Universitaire de Saint-Etienne, 42000, Saint-Etienne, France
                [f ]Centre Hospitalo-Universitaire de Strasbourg, 67000, Strasbourg, France
                [g ]Hôpital Saint-Joseph, 13000, Marseille, France
                [h ]Hospices civiles de Lyon, 69000, Lyon, France
                [i ]Centre Hospitalo-Universitaire de Caen, 14000, Caen, France
                [j ]Centre Hospitalo-Universitaire Clermont-Ferrand, 63000, Clermont-Ferrand, France
                [k ]Centre Hospitalier Régional Universitaire de Lille, 59000, Lille, France
                [l ]Centre hospitalier intercommunal de Créteil, 94000, Créteil, France
                [m ]Maternité Régionale de Nancy, 54000, Nancy, France
                [n ]Centre Hospitalier Régional Universitaire de Tours, 37000, Tours, France
                [o ]Centre Hospitalier Intercommunal de Poissy, 78300, Poissy, France
                [p ]Centre Hospitalo-Universitaire de Bordeaux, 33000, Bordeaux, France
                [q ]Centre Hospitalo-Universitaire de Toulouse, 31000, Toulouse, France
                [r ]Centre Hospitalo-Universitaire de Rouen, 76000, Rouen, France
                [s ]Centre Hospitalo-Universitaire de Nantes, 44000, Nantes, France
                Author notes
                [* ]Corresponding author at: Assistance Publique des Hôpitaux de Paris, Hôpital Trousseau, Service de Gynécologie Obstétrique, 26 rue du Dr Arnold Netter, 75012, Paris, France. gkayem@ 123456gmail.com
                [1]

                The Groupe de Recherche en Obstétrique et Gynécologie (GROG) authors.

                [2]

                Group leader.

                Article
                S2468-7847(20)30170-7 101826
                10.1016/j.jogoh.2020.101826
                7270811
                32505805
                a9de6723-28f7-4830-9dc6-9744ef5d283b
                © 2020 Elsevier Masson SAS. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 29 May 2020
                : 31 May 2020
                Categories
                Article

                covid 19,respiratory complications,risk factors,lockdown

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content361

                Cited by92

                Most referenced authors1,776